Stockscreener 앱 받기
1.205
2.12%
0.025
전일 마감가:
$1.18
열려 있는:
$1.19
하루 거래량:
97,669
Relative Volume:
0.98
시가총액:
$9.08M
수익:
-
순이익/손실:
$-25.56M
주가수익비율:
-0.2317
EPS:
-5.2
순현금흐름:
$-19.35M
1주 성능:
-5.12%
1개월 성능:
-15.73%
6개월 성능:
-83.52%
1년 성능:
-45.96%
1일 변동 폭
$1.18
$1.24
1주일 범위
$1.14
$1.3399
52주 변동 폭
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
명칭
Biovie Inc
전화
775-888-3162
주소
680 W NYE LANE, CARSON CITY
BIVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.205 | 8.89M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-15 | 개시 | B. Riley Securities | Buy |
Biovie Inc 주식(BIVI)의 최신 뉴스
Short Covering: Will BioVie Inc outperform the market in YEARWeekly Trade Summary & Daily Momentum Trading Reports - baoquankhu1.vn
New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew - Columbia Daily Tribune
BioVie hits enrolment milestone in early Parkinson’s trial, data due later this year - Proactive financial news
BioVie (NASDAQ:BIVI) Stock Price Down 4.7% – Should You Sell? - Defense World
BioVie | 4: Statement of changes in beneficial ownership of securities-Officer Palumbo Joseph M - 富途牛牛
Is Biovie's SUNRISE-PD The First Light Of Change In Early Parkinson's? - RTTNews
Why BioVie Inc. stock is rated strong buyJuly 2025 Short Interest & Fast Moving Trade Plans - Улправда
Will BioVie Inc. stock benefit from infrastructure spendingWeekly Profit Summary & Technical Pattern Based Buy Signals - ulpravda.ru
Is BioVie Inc. stock cheap compared to fundamentalsJuly 2025 Outlook & Safe Entry Point Identification - Улправда
Why retail investors pile into BioVie Inc. stockQuarterly Profit Review & Safe Capital Investment Plans - Улправда
Will BioVie Inc. stock see insider buyingMarket Activity Report & Expert Approved Momentum Ideas - Улправда
Stock Analysis: How supply chain issues affect BioVie Inc. stockNew Guidance & Fast Exit Strategy with Risk Control - Улправда
BioVie completes enrollment for Parkinson’s drug trial By Investing.com - Investing.com Australia
BioVie completes enrollment for Parkinson’s drug trial - Investing.com
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease - GlobeNewswire
Is BioVie Inc. stock dividend yield sustainableSmall Cap Stock Opportunities & Affordable Market Insights - Улправда
Aug Shorts: Why BioVie Inc stock is rated strong buyWeekly Stock Analysis & High Accuracy Trade Signal Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - The Malaysian Reserve
BioVie (NASDAQ:BIVI) Trading Down 5.8% – What’s Next? - Defense World
BioVie Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Real-Time Stock Market Data - earlytimes.in
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
Will BioVie Inc. stock outperform Dow Jones indexJuly 2025 Snapshot & Fast Gain Stock Trading Tips - ulpravda.ru
BioVie advances lead drug candidatesICYMI - Proactive financial news
Breakout Zone: Will BioVie Inc. stock outperform Dow Jones indexJobs Report & Reliable Price Breakout Alerts - Улправда
What Wall Street predicts for BioVie Inc. stock priceMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Aug Movers: How BioVie Inc. stock compares to industry benchmarksJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
How BioVie Inc. stock compares to industry benchmarks2025 EndofYear Setup & Precise Buy Zone Identification - ulpravda.ru
Fund Flows: What momentum indicators show for BioVie Inc. stockJuly 2025 Outlook & Daily Chart Pattern Signal Reports - Улправда
What momentum indicators show for BioVie Inc. stockQuarterly Performance Summary & Technical Confirmation Trade Alerts - Улправда
BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026 - Proactive financial news
What makes BioVie (BIVI) a new buy stock - MSN
What Makes BioVie (BIVI) a New Buy Stock - sharewise.com
BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver DiseaseSlideshow (NASDAQ:BIVI) 2025-12-09 - Seeking Alpha
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth - The Florida Times-Union
Breakout Watch: How BioVie Inc. stock compares to industry benchmarksPortfolio Performance Summary & Safe Capital Growth Trade Ideas - BỘ NỘI VỤ
Can BioVie Inc. stock sustain institutional interestJuly 2025 Review & Low Drawdown Trading Strategies - Newser
BioVie Inc. (BIVI) -5.7% in After-hours: Stock Declines Amid Routine Trading Conditions - Stocks Telegraph
BioVie (NASDAQ:BIVI) Shares Up 0.3% – Here’s What Happened - Defense World
BIVI SEC FilingsBiovie Inc 10-K, 10-Q, 8-K Forms - Stock Titan
[S-8] BIOVIE INC. Employee Benefit Plan Registration | BIVI SEC FilingForm S-8 - Stock Titan
BIVIW Insider Trading - Quiver Quantitative
BIVIW | BioVie Inc. Warrant Stock Data, Price & News - Quiver Quantitative
BioVie Inc. (BIVI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What drives BioVie Inc stock pricePrice Support Zones & Free Record-Breaking Gains - earlytimes.in
What catalysts could drive BioVie Inc. stock higherMarket Performance Summary & Consistent Growth Stock Picks - newser.com
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound - Nasdaq
Biovie Inc (BIVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):